{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T18:21:26Z","timestamp":1790878886640,"version":"4.1.0"},"reference-count":42,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Kidney360"],"published-print":{"date-parts":[[2021,4]]},"abstract":"<jats:sec>\n                    <jats:title>Key Points<\/jats:title>\n                    <jats:p>\n                      <jats:list list-type=\"bullet\">\n                        <jats:list-item>\n                          <jats:p>Citric acid\u2013containing dialysate for hemodialysis was prescribed to 20%\u201325% of patients in Japanese, Italian, and Belgium centers in the Dialysis Outcomes and Practice Patterns Study.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>The use of citric acid\u2013containing bicarbonate-based dialysate was not associated with mortality in the international Dialysis Outcomes and Practice Patterns Study cohort.<\/jats:p>\n                        <\/jats:list-item>\n                      <\/jats:list>\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Metabolic acidosis is a common threat for patients on hemodialysis, managed by alkaline dialysate. The main base is bicarbonate, to which small amounts of acetic, citric, or hydrochloric acid are added. The first two are metabolized to bicarbonate, mostly by the liver. Citric acid\u2013containing dialysate might improve dialysis efficiency, anticoagulation, calcification propensity score, and intradialytic hemodynamic stability. However, a recent report from the French dialysis registry suggested this dialysate increases mortality risk. This prompted us to assess whether citric acid\u2013containing bicarbonate-based dialysate was associated with mortality in the international Dialysis Outcomes and Practice Patterns Study (DOPPS).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Detailed patient-based information on dialysate composition was collected in DOPPS phases 5 and 6 (2012\u20132017). Cox regression was used to model the association between baseline bicarbonate dialysate containing citric acid versus not containing citric acid and mortality among DOPPS countries and phases where citric acid\u2013containing dialysate was used.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Citric acid-containing dialysate was most commonly used in Japan, Italy, and Belgium (25%, 25%, 21% and of patients who were DOPPS phase 6, respectively) and used in &lt;10% of patients in other countries. Among 11,306 patients in DOPPS country and phases with at least 15 patients using citric acid-containing dialysate, patient demographics, comorbidities, and laboratories were similar among patients using (14%) versus not using (86%) citric acid-containing dialysate. After accounting for case mix, we did not observe a directional association between citric acid\u2013containing dialysate use (any versus none) and mortality (HR, 1.14; 95% CI, 0.97 to 1.34), nor did we find evidence of a dose-dependent relationship when parameterizing the citric acid concentration in the dialysate as 1, 2, and 3+ mEq\/L.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The use of citric acid\u2013containing dialysate was not associated with greater risk of all-cause mortality in patients on hemodialysis participating in DOPPS. Clinical indications for the use of citric acid\u2013containing dialysate deserve further investigation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.34067\/kid.0006182020","type":"journal-article","created":{"date-parts":[[2021,2,4]],"date-time":"2021-02-04T18:23:11Z","timestamp":1612462991000},"page":"666-673","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":9,"title":["Citric Acid\u2013Containing Dialysate and Survival Rate in the Dialysis Outcomes and Practice Patterns Study"],"prefix":"10.34067","volume":"2","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6757-1906","authenticated-orcid":false,"given":"Pablo","family":"Ure\u00f1a-Torres","sequence":"first","affiliation":[{"name":"Department of Dialysis, Association pour l'Utilisation du Rein Artificiel en Ile de France, Nord Saint Ouen, Saint Ouen, France"},{"name":"Department of Renal Physiology, Necker Hospital, University of Paris Descartes, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Bieber","sequence":"additional","affiliation":[{"name":"Dialysis Outcomes and Practice Patterns Study (DOPPS) Coordinating Center, Arbor Research Collaborative for Health, Ann Arbor, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fitsum","family":"Guebre-Egziabher","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Hypertension and Dialysis, Hospices Civils de Lyon, H\u00f4pital Edouard Herriot, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rim","family":"Ossman","sequence":"additional","affiliation":[{"name":"Department of Dialysis, Association pour l'Utilisation du Rein Artificiel en Ile de France, Nord Saint Ouen, Saint Ouen, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Jadoul","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Dialysis. Universitary Clinics Saint Luc, Catholic University of Louvain, Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaaki","family":"Inaba","sequence":"additional","affiliation":[{"name":"Department of Metabolism, Endocrinology and Molecular Medicine, Osaka City University Graduate School of Medicine, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce M.","family":"Robinson","sequence":"additional","affiliation":[{"name":"Dialysis Outcomes and Practice Patterns Study (DOPPS) Coordinating Center, Arbor Research Collaborative for Health, Ann Arbor, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Friedrich","family":"Port","sequence":"additional","affiliation":[{"name":"Dialysis Outcomes and Practice Patterns Study (DOPPS) Coordinating Center, Arbor Research Collaborative for Health, Ann Arbor, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Jacquelinet","sequence":"additional","affiliation":[{"name":"Department of Biomedicine, Agence de la Biom\u00e9dicine, Saint Denis La Plaine, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Combe","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Transplantation, Dialysis and Apheresis, Centre Hospitalo-Universitaire de Bordeaux and Institute National de la Sant\u00e9 et de la Recherche M\u00e9dicale U1026, Universit\u00e9 de Bordeaux, Bordeaux, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,4,29]]},"reference":[{"key":"B1-20250825","first-page":"110","article-title":"Substitution of sodium acetate for sodium bicarbonate in the bath fluid for hemodialysis","volume":"10","author":"Mion","year":"1964","journal-title":"Trans Am Soc Artif Intern Organs"},{"key":"B2-20250825","doi-asserted-by":"crossref","first-page":"312","DOI":"10.7326\/0003-4819-66-2-312","article-title":"Quantitative displacement of acid-base equilibrium in metabolic acidosis","volume":"66","author":"Albert","year":"1967","journal-title":"Ann Intern Med"},{"key":"B3-20250825","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/ki.1982.54","article-title":"Acetate and bicarbonate fluctuations and acetate intolerance during dialysis","volume":"21","author":"Pagel","year":"1982","journal-title":"Kidney Int"},{"key":"B4-20250825","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1681\/ASN.V891431","article-title":"Acetate intolerance is mediated by enhanced synthesis of nitric oxide by endothelial cells","volume":"8","author":"Amore","year":"1997","journal-title":"J Am Soc Nephrol"},{"key":"B5-20250825","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0140-6736(87)90703-3","article-title":"Enhancement of in-vitro human interleukin-1 production by sodium acetate","volume":"1","author":"Bingel","year":"1987","journal-title":"Lancet"},{"key":"B6-20250825","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1111\/j.1744-9987.2011.00976.x","article-title":"Comparison of acetate-free citrate hemodialysis and bicarbonate hemodialysis regarding the effect of intra-dialysis hypotension and post-dialysis malaise","volume":"15","author":"Daimon","year":"2011","journal-title":"Ther Apher Dial"},{"key":"B7-20250825","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1046\/j.1525-1594.1998.06205.x","article-title":"Substitution of acetic acid for hydrochloric acid in the bicarbonate buffered dialysate","volume":"22","author":"Fournier","year":"1998","journal-title":"Artif Organs"},{"key":"B8-20250825","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.2215\/CJN.02590409","article-title":"Increased efficiency of hemodialysis with citrate dialysate: A prospective controlled study","volume":"4","author":"Kossmann","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"B9-20250825","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1159\/000087193","article-title":"Does bicarbonate transfer have relevant hemodynamic consequences in standard hemodialysis?","volume":"23","author":"Gabutti","year":"2005","journal-title":"Blood Purif"},{"key":"B10-20250825","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1111\/aor.12851","article-title":"Citrate-buffered dialysis solution (citrasate) allows avoidance of anticoagulation during intermittent hemodiafiltration-at the cost of decreased performance and systemic biocompatibility","volume":"41","author":"Richtrova","year":"2017","journal-title":"Artif Organs"},{"key":"B11-20250825","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1093\/ndt\/gfy134","article-title":"Acetate-free, citrate-acidified bicarbonate dialysis improves serum calcification propensity-a preliminary study","volume":"33","author":"Lorenz","year":"2018","journal-title":"Nephrol Dial Transplant"},{"key":"B12-20250825","doi-asserted-by":"crossref","first-page":"e0225824","DOI":"10.1371\/journal.pone.0225824","article-title":"Citric-acid dialysate improves the calcification propensity of hemodialysis patients: A multicenter prospective randomized cross-over trial","volume":"14","author":"Ter Meulen","year":"2019","journal-title":"PLoS One"},{"key":"B13-20250825","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1007\/s10047-010-0551-7","article-title":"Acetate-free blood purification can impact improved nutritional status in hemodialysis patients","volume":"14","author":"Matsuyama","year":"2011","journal-title":"J Artif Organs"},{"key":"B14-20250825","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1186\/s12882-017-0683-6","article-title":"The dynamics of the metabolism of acetate and bicarbonate associated with use of hemodialysates in the ABChD trial: A phase IV, prospective, single center, single blind, randomized, cross-over, two week investigation","volume":"18","author":"Smith","year":"2017","journal-title":"BMC Nephrol"},{"key":"B15-20250825","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.nefro.2016.09.017","article-title":"Calcium mass balance with citrate dialysate is lower than with acetate","volume":"37","author":"P\u00e9rez-Garc\u00eda","year":"2017","journal-title":"Nefrologia"},{"key":"B16-20250825","first-page":"S349","article-title":"MON-110 effect of acid of dialysate on survival in the French REIN registry","volume":"4","author":"Mercadal","year":"2019","journal-title":"Kidney Int Rep"},{"key":"B17-20250825","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1053\/j.ajkd.2013.03.035","article-title":"Association of dialysate bicarbonate concentration with mortality in the Dialysis Outcomes and Practice Patterns Study (DOPPS)","volume":"62","author":"Tentori","year":"2013","journal-title":"Am J Kidney Dis"},{"issue":"Suppl 2","key":"B18-20250825","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0272-6386(04)01099-6","article-title":"The Dialysis Outcomes and Practice Patterns Study (DOPPS): Design, data elements, and methodology","volume":"44","author":"Pisoni","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"B19-20250825","doi-asserted-by":"crossref","first-page":"S74","DOI":"10.1046\/j.1523-1755.2000.07413.x","article-title":"The Dialysis Outcomes and Practice Patterns Study (DOPPS): An international hemodialysis study","volume":"57","author":"Young","year":"2000","journal-title":"Kidney Int"},{"key":"B21-20250825","first-page":"219","article-title":"Citrate haemodialysis","volume":"37","author":"Faber","year":"1990","journal-title":"Neth J Med"},{"key":"B22-20250825","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1186\/s12882-019-1450-7","article-title":"Effect of dialysate potassium and lactate on serum potassium and bicarbonate concentrations during daily hemodialysis at low dialysate flow rates","volume":"20","author":"Leypoldt","year":"2019","journal-title":"BMC Nephrol"},{"key":"B23-20250825","doi-asserted-by":"crossref","first-page":"4","DOI":"10.7243\/2050-1218-3-4","article-title":"The status of citrate in the hydroxyapatite\/collagen complex of bone; and its role in bone formation","volume":"3","author":"Costello","year":"2014","journal-title":"J Regen Med Tissue Eng"},{"key":"B24-20250825","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/1876525401406010001","article-title":"Evidence that osteoblasts are specialized citrate-producing cells that provide the citrate for incorporation into the structure of bone","volume":"6","author":"Franklin","year":"2014","journal-title":"Open Bone J"},{"key":"B25-20250825","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1186\/1471-2369-14-216","article-title":"Replacement of acetate with citrate in dialysis fluid: A randomized clinical trial of short term safety and fluid biocompatibility","volume":"14","author":"Grundstr\u00f6m","year":"2013","journal-title":"BMC Nephrol"},{"key":"B26-20250825","first-page":"439","article-title":"Citrate anticoagulation for continuous renal replacement therapy (CRRT) in patients with acute kidney injury admitted to the intensive care unit","volume":"2","author":"Davenport","year":"2009","journal-title":"NDT Plus"},{"key":"B27-20250825","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/ki.1988.223","article-title":"The untoward effects of the anions of dialysis fluids","volume":"34","author":"Veech","year":"1988","journal-title":"Kidney Int"},{"key":"B28-20250825","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1097\/CCM.0000000000001004","article-title":"A randomized controlled trial of regional citrate versus regional heparin anticoagulation for continuous renal replacement therapy in critically ill adults","volume":"43","author":"Gattas","year":"2015","journal-title":"Crit Care Med"},{"key":"B29-20250825","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1093\/ndt\/gfg383","article-title":"Unexpected haemodynamic instability associated with standard bicarbonate haemodialysis","volume":"18","author":"Gabutti","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"B30-20250825","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2369-10-7","article-title":"Citrate- vs. acetate-based dialysate in bicarbonate haemodialysis: Consequences on haemodynamics, coagulation, acid-base status, and electrolytes","volume":"10","author":"Gabutti","year":"2009","journal-title":"BMC Nephrol"},{"key":"B31-20250825","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1093\/ndt\/gfaa089","article-title":"Long-term mortality risk associated with citric acid- and acetic acid-based bicarbonate haemodialysis: A historical cohort propensity score-matched study in a large, multicentre, population-based study","volume":"35","author":"Neri","year":"2020","journal-title":"Nephrol Dial Transplant"},{"key":"B32-20250825","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1159\/000502939","article-title":"Impact of long-term citrate dialysate use on survival in haemodialysis patients","volume":"49","author":"Seret","year":"2020","journal-title":"Blood Purif"},{"key":"B33-20250825","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1093\/ndt\/gfz274","article-title":"Long-term effects of citric acid-based bicarbonate haemodialysis on patient outcomes: A survival propensity score-matched study in western France","volume":"35","author":"Potier","year":"2020","journal-title":"Nephrol Dial Transplant"},{"key":"B34-20250825","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1093\/ndt\/gfaa168","article-title":"Impact of the dialysate acid component on haemodialysis mortality rates","volume":"35","author":"Couchoud","year":"2020","journal-title":"Nephrol Dial Transplant"},{"key":"B35-20250825","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1182\/blood.V63.5.996.996","article-title":"Factor VIII-von Willebrand factor requires calcium for facilitation of platelet adherence","volume":"63","author":"Sakariassen","year":"1984","journal-title":"Blood"},{"key":"B36-20250825","first-page":"26","article-title":"Issues with heparin, and the role of citrate","volume":"22","author":"Kossmann","year":"2008","journal-title":"Nephrol News Issues"},{"key":"B37-20250825","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1159\/000334157","article-title":"Effects of citrate acid concentrate (citrasate\u00ae) on heparin N requirements and hemodialysis adequacy: A multicenter, prospective noninferiority trial","volume":"33","author":"Sands","year":"2012","journal-title":"Blood Purif"},{"key":"B38-20250825","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1093\/ndt\/gfv347","article-title":"Effects of citrate dialysate in chronic dialysis: A multicentre randomized crossover study","volume":"31","author":"Schmitz","year":"2016","journal-title":"Nephrol Dial Transplant"},{"key":"B39-20250825","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1097\/01.CCM.0000084871.76568.E6","article-title":"Citrate pharmacokinetics and metabolism in cirrhotic and noncirrhotic critically ill patients","volume":"31","author":"Kramer","year":"2003","journal-title":"Crit Care Med"},{"key":"B40-20250825","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1093\/bja\/aew277","article-title":"The role of bicarbonate precursors in balanced fluids during haemorrhagic shock with and without compromised liver function","volume":"117","author":"Ergin","year":"2016","journal-title":"Br J Anaesth"},{"key":"B41-20250825","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/hdi.12113","article-title":"Effects of citrate-enriched bicarbonate based dialysate on anticoagulation and dialyzer reuse in maintenance hemodialysis patients","volume":"18","author":"Rocha","year":"2014","journal-title":"Hemodial Int"},{"key":"B42-20250825","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1159\/000490612","article-title":"Microbiota quality and mitochondrial activity link with occurrence of muscle cramps in hemodialysis patients using citrate dialysate: A pilot study","volume":"46","author":"Durand","year":"2018","journal-title":"Blood Purif"},{"key":"B43-20250825","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1620\/tjem.227.217","article-title":"Biotin ameliorates muscle cramps of hemodialysis patients: A prospective trial","volume":"227","author":"Oguma","year":"2012","journal-title":"Tohoku J Exp Med"}],"container-title":["Kidney360"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.34067\/KID.0006182020","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T20:02:03Z","timestamp":1786478523000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.34067\/KID.0006182020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.34067\/kid.0006182020","relation":{},"ISSN":["2641-7650"],"issn-type":[{"value":"2641-7650","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"2020-10-15","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-01-18","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}